Medical Nutrition Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type, By Indication, By End User, By Route of Administration, and Region
Medical Nutrition Market size was valued at US$ 48.9 billion in 2023 and is poised to grow at a CAGR of 3.7% from 2024 to 2030. Medical nutrition is an evidence-based, individualised nutrition process to help treat certain medical conditions. It is a relationship between diet, nutrition, and health outcomes. It includes giving the right foods or nutrients to treat conditions such as those caused by diabetes, heart disease, and cancer. The increasing prevalence of metabolic disorders, high spending on healthcare, and increasing disposable income of the public are expected to drive the growth of the
global medical nutrition market over the forecast period. Besides this, various government initiatives like celebration of National Nutrition Month, the UN Decade of Action on Nutrition and others are booming the major influencers of global medical nutrition market growth. Furthermore, collaborations, partnerships, mergers, and acquisitions are stipulating the growth of the market. For instance, In September 2023, RxFood Corporation, a company specializing in AI-driven personalized nutrition assessments, and Dexcom, Inc., a global leader in real-time continuous glucose monitoring (rtCGM) for individuals with diabetes, announced a unique partnership in Canada. However, side effects and complications of nutritional products, product recalls, and stringent regulations pose a threat to manufacturers.
Study Period
2024 - 2030Base Year
2023CAGR
3.7%Largest Market
North AmericaFastest Growing Market
Asia pacific
The incidence of chronic diseases like cancer, heart disease, gastrointestinal disorders, respiratory issues, and malnutrition is increasing among both adults and children, necessitating greater emphasis on nutritional support. While commonly associated with older individuals, oropharyngeal dysphagia is also prevalent in those with neurological conditions such as multiple sclerosis, Parkinson's disease, and dementia. This condition's swallowing difficulties underscore the importance of clinical nutrition, particularly as the global prevalence of neurological disorders continues to rise. A 2022 WHO report projected that by 2030, there could be 78 million people with dementia, and by 2050, this number could rise to 139 million. The prevalence of chronic diseases has been steadily increasing over the past few decades. The surge in chronic diseases like diabetes, cancer, and heart disease has boosted demand for specialized medical nutrition products. For instance, in 2020, about 697,000 deaths in the U.S. were attributed to heart disease, with around 20.1 million adults affected by coronary artery disease (CAD). Given the lifelong management required, there's a growing need for tailored dietary interventions through formulated food products. Rising healthcare costs have also spurred focus on preventive measures like medical nutrition therapy, supported by awareness programs emphasizing the role of nutrition in chronic disease management.
By region, the study provides the market insights of North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America’s medical nutrition market accounted for the highest revenue and is expected to exhibit significant CAGR growth during the forecasted period. Additionally, Europe's medical nutrition market also accounts for a significant market share due to the availability of cutting-edge treatment facilities, European government expenditure on the healthcare industry, and the increasing ageing population. Furthermore, the Asia-Pacific medical nutrition market is expected to grow at the fastest CAGR during the forecast period owing to the increasing number of the geriatric population, the rapidly growing tourism industry, and increase in health awareness among the people in the developing nations in APAC. However, in the middle and low-income nations, in 2022, an estimated 149 million children under the age of 5 years were suffering from stunting, while 37 million were living with overweight or obesity. Nearly half of deaths among children under 5 years of age are linked to undernutrition.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024 - 2030 |
|
Market Size in 2023 |
US$ 48.9 billion |
|
Market CAGR |
3.7% |
|
By Product |
|
|
By Indication |
|
|
By End User |
|
|
By Route of Administration |
|
Download Free Sample Report
The global medical nutrition market was valued at US$ 48.9 billion in 2023 and is forecasted to grow at a CAGR of 3.7% from 2024 to 2030.
The global medical nutrition market is segmented based on product type, indication, end user, route of administration, and geography.
The leading players are Solace Nutrition (U.K.), AYMES Nutrition International Ltd., Mead Johnson and Company LLC., Nestle Health Science, Braun Melsungen AG, NeoMed, Abbott Nutrition, Baxter International, Danone, GSK PLC., Sanofi, Leprino Foods Company, Esperer Onco Nutrition, Fresenius SE & Co. KGaA, and Kate Farms
North America tops the global medical nutrition market.
The increasing prevalence of metabolic disorders, high spending on healthcare, increasing disposable income of the public, various government initiatives collaborations, partnerships, mergers, and acquisitions are the key trends in the global medical nutrition market report.
| 1. Executive Summary |
| 2. Global Medical Nutrition Market Introduction |
| 2.1.Global Medical Nutrition Market - Taxonomy |
| 2.2.Global Medical Nutrition Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Indication |
| 2.2.3.End Users |
| 2.2.4. Route of Administration |
| 2.2.5.Region |
| 3. Global Medical Nutrition Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Medical Nutrition Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Medical Nutrition Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Proteins |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Carbohydrates |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Multivitamins |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Antioxidants |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Fibers |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Trace elements |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Supplements |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Minerals |
| 5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6. Global Medical Nutrition Market By Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Diabetes |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Cancer |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Gastrointestinal Diseases |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Metabolic Syndromes |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Obesity |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Malnutrition |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Pulmonary disease |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7.Global Medical Nutrition Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Pediatric Nutrition |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Geriatric Nutrition |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Sports Nutrition |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Adult Nutrition |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Medical Nutrition Market By Route of Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Oral |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Parenteral |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Enteral |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Medical Nutrition Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Medical Nutrition Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Proteins |
| 10.1.2.Carbohydrates |
| 10.1.3.Multivitamins |
| 10.1.4.Antioxidants |
| 10.1.5.Fibers |
| 10.1.6.Trace elements |
| 10.1.7.Supplements |
| 10.1.8.Minerals |
| 10.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Diabetes |
| 10.2.2.Cancer |
| 10.2.3.Gastrointestinal Diseases |
| 10.2.4.Metabolic Syndromes |
| 10.2.5.Obesity |
| 10.2.6.Malnutrition |
| 10.2.7.Pulmonary disease |
| 10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pediatric Nutrition |
| 10.3.2.Geriatric Nutrition |
| 10.3.3.Sports Nutrition |
| 10.3.4.Adult Nutrition |
| 10.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Oral |
| 10.4.2.Parenteral |
| 10.4.3.Enteral |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Medical Nutrition Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Proteins |
| 11.1.2.Carbohydrates |
| 11.1.3.Multivitamins |
| 11.1.4.Antioxidants |
| 11.1.5.Fibers |
| 11.1.6.Trace elements |
| 11.1.7.Supplements |
| 11.1.8.Minerals |
| 11.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Diabetes |
| 11.2.2.Cancer |
| 11.2.3.Gastrointestinal Diseases |
| 11.2.4.Metabolic Syndromes |
| 11.2.5.Obesity |
| 11.2.6.Malnutrition |
| 11.2.7.Pulmonary disease |
| 11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pediatric Nutrition |
| 11.3.2.Geriatric Nutrition |
| 11.3.3.Sports Nutrition |
| 11.3.4.Adult Nutrition |
| 11.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Oral |
| 11.4.2.Parenteral |
| 11.4.3.Enteral |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Medical Nutrition Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Proteins |
| 12.1.2.Carbohydrates |
| 12.1.3.Multivitamins |
| 12.1.4.Antioxidants |
| 12.1.5.Fibers |
| 12.1.6.Trace elements |
| 12.1.7.Supplements |
| 12.1.8.Minerals |
| 12.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Diabetes |
| 12.2.2.Cancer |
| 12.2.3.Gastrointestinal Diseases |
| 12.2.4.Metabolic Syndromes |
| 12.2.5.Obesity |
| 12.2.6.Malnutrition |
| 12.2.7.Pulmonary disease |
| 12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pediatric Nutrition |
| 12.3.2.Geriatric Nutrition |
| 12.3.3.Sports Nutrition |
| 12.3.4.Adult Nutrition |
| 12.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Oral |
| 12.4.2.Parenteral |
| 12.4.3.Enteral |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Medical Nutrition Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Proteins |
| 13.1.2.Carbohydrates |
| 13.1.3.Multivitamins |
| 13.1.4.Antioxidants |
| 13.1.5.Fibers |
| 13.1.6.Trace elements |
| 13.1.7.Supplements |
| 13.1.8.Minerals |
| 13.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Diabetes |
| 13.2.2.Cancer |
| 13.2.3.Gastrointestinal Diseases |
| 13.2.4.Metabolic Syndromes |
| 13.2.5.Obesity |
| 13.2.6.Malnutrition |
| 13.2.7.Pulmonary disease |
| 13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pediatric Nutrition |
| 13.3.2.Geriatric Nutrition |
| 13.3.3.Sports Nutrition |
| 13.3.4.Adult Nutrition |
| 13.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Oral |
| 13.4.2.Parenteral |
| 13.4.3.Enteral |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Medical Nutrition Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Proteins |
| 14.1.2.Carbohydrates |
| 14.1.3.Multivitamins |
| 14.1.4.Antioxidants |
| 14.1.5.Fibers |
| 14.1.6.Trace elements |
| 14.1.7.Supplements |
| 14.1.8.Minerals |
| 14.2. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Diabetes |
| 14.2.2.Cancer |
| 14.2.3.Gastrointestinal Diseases |
| 14.2.4.Metabolic Syndromes |
| 14.2.5.Obesity |
| 14.2.6.Malnutrition |
| 14.2.7.Pulmonary disease |
| 14.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Pediatric Nutrition |
| 14.3.2.Geriatric Nutrition |
| 14.3.3.Sports Nutrition |
| 14.3.4.Adult Nutrition |
| 14.4. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Oral |
| 14.4.2.Parenteral |
| 14.4.3.Enteral |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Solace Nutrition (U.K.) |
| 15.2.2.AYMES Nutrition International Ltd. |
| 15.2.3.Mead Johnson and Company LLC. |
| 15.2.4.Nestle Health Science |
| 15.2.5.Braun Melsungen AG |
| 15.2.6.NeoMed |
| 15.2.7.Abbott Nutrition |
| 15.2.8.Baxter International |
| 15.2.9.Danone |
| 15.2.10.GSK PLC. |
| 15.2.11.Sanofi |
| 15.2.12.Leprino Foods Company |
| 15.2.13.Esperer Onco Nutrition |
| 15.2.14.Fresenius SE & Co. KGaA |
| 15.2.15.Kate Farms |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
